Compound Evidence File
#EC-2026-0705
Oxytocin Acetate
Filed under Peptides. The bureau holds 186 laboratory returns for this compound from 79 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
79 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 10.0 | 10.0 | 8 Feb 2026 | 13 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 9.9 | 10.0 | 12 Dec 2025 | 15 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Jan 2026 | 13 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 28 Jan 2026 | 11 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 1 May 2026 | 14 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 10.0 | 10.0 | 3 Feb 2026 | 26 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 10.0 | 10.0 | 18 Apr 2026 | 9 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 11 Mar 2026 | 26 Jun 2026 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 10.0 | 10.0 | 10.0 | 20 Jun 2025 | 20 Jun 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Jun 2026 | 25 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Mar 2026 | 25 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Jun 2026 | 15 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 14 May 2026 | 10 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 10.0 | 1 May 2026 | 7 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 10.0 | 12 Jun 2026 | 24 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 13 Mar 2026 | 12 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 9.9 | 9.9 | 10.0 | 27 Dec 2025 | 20 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 16 Feb 2026 | 8 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Mar 2026 | 14 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Mar 2026 | 22 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Jan 2026 | 4 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 6 Apr 2026 | 9 Jul 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 9.0 | 9.0 | 9.0 | 13 Jun 2025 | 13 Jun 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 9.0 | 9.0 | 9.0 | 3 Jul 2025 | 3 Jul 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 8.9 | 8.9 | 8.9 | 25 May 2026 | 25 May 2026 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 8.9 | 8.9 | 8.9 | 9 Jun 2025 | 9 Jun 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 8.8 | 8.8 | 8.8 | 2 Apr 2025 | 2 Apr 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.7 | 7.5 | 10.0 | 24 May 2026 | 24 May 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 8.4 | 8.4 | 8.4 | 13 Jun 2025 | 13 Jun 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.3 | 7.2 | 9.8 | 24 May 2026 | 24 May 2026 |
| Xingruida XDRCASE #VI-2026-0898 | X | 6 | 8.3 | 7.4 | 9.9 | 2 Apr 2025 | 26 Jan 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.2 | 7.6 | 8.9 | 24 May 2026 | 24 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 2 | 8.2 | 7.8 | 8.5 | 16 Mar 2025 | 21 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.1 | 6.7 | 8.8 | 24 May 2026 | 24 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 8.1 | 8.1 | 8.1 | 7 May 2025 | 7 May 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 | 3 Jul 2025 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 8.1 | 8.1 | 8.1 | 20 Jun 2025 | 20 Jun 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 8.1 | 8.1 | 8.1 | 25 Apr 2025 | 25 Apr 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 2 | 8.0 | 7.0 | 9.0 | 20 Jun 2025 | 17 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 8 | 7.7 | 3.8 | 10.0 | 25 Apr 2025 | 21 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 7.7 | 7.7 | 7.7 | 13 Feb 2025 | 13 Feb 2025 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 | 8 Jul 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 1 | 7.4 | 7.4 | 7.4 | 8 Jul 2025 | 8 Jul 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 3 | 7.2 | 5.4 | 8.2 | 21 May 2025 | 23 May 2026 |
| Verified PeptidesCASE #VI-2026-0407 | X | 3 | 7.1 | 6.0 | 8.0 | 14 Jan 2025 | 24 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 | 25 Apr 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 1 | 7.0 | 7.0 | 7.0 | 8 Jul 2025 | 8 Jul 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 7.0 | 7.0 | 7.0 | 11 Jun 2025 | 11 Jun 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 6.8 | 6.4 | 7.2 | 11 Jun 2025 | 19 Jan 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 6.8 | 6.8 | 6.8 | 13 Feb 2025 | 13 Feb 2025 |
| Zztai PeptideCASE #VI-2026-0192 | X | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 | 13 Jun 2025 |
| Peptide SciencesCASE #VI-2026-0867 | X | 12 | 6.7 | 4.5 | 8.1 | 3 Jun 2025 | 17 May 2026 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 | 9 Jun 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 | 6 May 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 6.6 | 6.6 | 6.6 | 24 Apr 2025 | 24 Apr 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 3 | 6.5 | 5.6 | 7.6 | 24 Apr 2025 | 21 May 2026 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 | 2 Apr 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 6.3 | 5.6 | 7.0 | 16 Mar 2025 | 23 May 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 6.2 | 6.2 | 6.2 | 17 Dec 2024 | 17 Dec 2024 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 6.1 | 6.1 | 6.1 | 2 Apr 2025 | 2 Apr 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 | 11 Jun 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 5.9 | 5.9 | 5.9 | 7 May 2025 | 7 May 2025 |
| UtherCASE #VI-2026-0902 | X | 3 | 5.8 | 4.5 | 6.6 | 2 Apr 2025 | 17 May 2026 |
| CellupepCASE #VI-2026-0888 | X | 1 | 5.6 | 5.6 | 5.6 | 6 May 2025 | 6 May 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 4.9 | 4.9 | 4.9 | 9 Jun 2025 | 9 Jun 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 4.9 | 4.9 | 4.9 | 14 Jan 2025 | 14 Jan 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 4.8 | 4.8 | 4.8 | 9 Jun 2025 | 9 Jun 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 3 | 4.7 | 3.4 | 6.4 | 16 Mar 2025 | 24 May 2026 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 4.6 | 4.6 | 4.6 | 8 Jul 2025 | 8 Jul 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 4.6 | 4.6 | 4.6 | 17 Dec 2024 | 17 Dec 2024 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 4.3 | 4.3 | 4.3 | 17 Dec 2024 | 17 Dec 2024 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 3.3 | 3.3 | 3.3 | 21 May 2025 | 21 May 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 2.8 | 2.8 | 2.8 | 13 Feb 2025 | 13 Feb 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 2.6 | 1.3 | 4.0 | 13 Jun 2025 | 24 May 2026 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.1 | 0.1 | 0.1 | 2 Jul 2025 | 2 Jul 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 0.0 | 0.0 | 0.0 | 9 Jun 2025 | 9 Jun 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 0.0 | 0.0 | 0.0 | 27 Feb 2025 | 27 Feb 2025 |
Open any subject to view the batch-level evidence for Oxytocin Acetate alone.